CRNX Competitors & Alternatives
Compare Crinetics Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
CRNX
Main Stock$37.39
Tradestie Score
55
Market Cap
$3.92B
Revenue Growth
28.7%
Analyst Upside
+123.1%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$103.74
|
$3.98B | - | 60 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$84.31
|
$3.91B | - | 57 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$19.98
|
$3.83B | - | 52 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$20.10
|
$3.68B | - | 50 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$111.15
|
$3.67B | - | 55 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.56
|
$3.59B | 11.6 | 49 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$22.20
|
$3.58B | 9.9 | 62 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$218.88
|
$3.49B | 28.7 | 55 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.86
|
$3.40B | - | 46 | Compare |
|
QURE
uniQure N.V.
|
$27.53
|
$3.39B | - | 58 | Compare |
More CRNX Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry